Mometasone Teva (Mometasone Furoate)

Mometasone furoate, the active ingredient in Mometasone Teva, is a corticosteroid presented as a nasal spray formulation for nasal use. It treats allergic rhinitis by reducing inflammation in the nasal passages of both adults and children.

GNH USA supplies Mometasone Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mometasone Teva is a corticosteroid nasal spray that targets inflammatory processes in the upper airway, primarily used for allergic conditions.

- Seasonal allergic rhinitis: relieves sneezing, nasal itching and congestion during pollen seasons. - Perennial allergic rhinitis: controls year‑round symptoms caused by indoor allergens. - Allergic rhinitis (overall): reduces nasal inflammation and improves airflow for patients of all ages.

Mometasone Teva may cause local and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nasal irritation or burning sensation. - Epistaxis (nosebleeds). - Headache. - Throat irritation. - Cough. - Unpleasant taste.

Serious or Rare Side Effects: - Nasal septal perforation. - Secondary infections such as fungal sinusitis. - Elevated intra‑ocular pressure or glaucoma. - Adrenal suppression with prolonged high‑dose use. - Systemic corticosteroid effects (e.g., hyperglycemia) in susceptible individuals. - Allergic reactions including rash or angioedema.

Before using Mometasone Teva, consider the following safety measures.

- Assess infection risk: avoid use if active nasal or sinus infection is present. - Monitor for ocular effects: patients with glaucoma or cataracts should be evaluated regularly. - Evaluate systemic exposure: prolonged high‑dose therapy may affect adrenal function. - Pregnancy and lactation: use only if the potential benefit justifies the potential risk. - Pediatric use: follow pediatric dosing guidelines provided by the prescriber. - Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Mometasone Teva can interact with other medications that influence corticosteroid metabolism or increase infection risk.

Major Interactions (Avoid): - Systemic CYP3A4 inhibitors (e.g., ketoconazole) that may increase systemic exposure. - Live vaccines: concurrent use may reduce vaccine efficacy.

Moderate Interactions (Monitor Closely): - Other intranasal corticosteroids: may increase local side effects. - Antifungal agents (e.g., itraconazole) that affect steroid clearance. - Immunosuppressants: heightened risk of infections. - Nasal decongestants: may mask signs of worsening inflammation. - Antihistamines: monitor for additive sedation if combined with sedating antihistamines.